Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin effects on endothelial injury and coagulation in severe pre-eclampsia after cesarean section
ChiCTR1800014898Phase 4Completed
- Sponsor
- Jianbo Wang
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ulinastatin in preeclampsia, sponsored by Jianbo Wang. Primary endpoint: vascular endothelial cell damage. Started Jan 2016; status: completed.
02
Drugs
ulinastatin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ChiCTR1800014898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014898.